Effect Of Foreign Exchange Rates - CJ Bioscience Inc (KOSDAQ:311690) - Alpha Spread
C

CJ Bioscience Inc
KOSDAQ:311690

Watchlist Manager
CJ Bioscience Inc
KOSDAQ:311690
Watchlist
Price: 12 000 KRW 1.1% Market Closed
Market Cap: 109.4B KRW
Have any thoughts about
CJ Bioscience Inc?
Write Note

CJ Bioscience Inc
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CJ Bioscience Inc
Effect of Foreign Exchange Rates Peer Comparison

Comparables:
U
032620
D
315640
e
099750
L
328130
J
322510

Competitive Effect of Foreign Exchange Rates Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
C
CJ Bioscience Inc
KOSDAQ:311690
Effect of Foreign Exchange Rates
â‚©26.7m
CAGR 3-Years
-13%
CAGR 5-Years
3%
CAGR 10-Years
N/A
U
UBCare Co Ltd
KOSDAQ:032620
Effect of Foreign Exchange Rates
-â‚©22.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
14%
D
DeepNoid Inc
KOSDAQ:315640
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
e
ezCaretech Co Ltd
KOSDAQ:099750
Effect of Foreign Exchange Rates
-â‚©31.3m
CAGR 3-Years
N/A
CAGR 5-Years
31%
CAGR 10-Years
N/A
L
Lunit Inc
KOSDAQ:328130
Effect of Foreign Exchange Rates
-â‚©121.5m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
JLK Inc
KOSDAQ:322510
Effect of Foreign Exchange Rates
-â‚©2.9m
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CJ Bioscience Inc's Effect of Foreign Exchange Rates?
Effect of Foreign Exchange Rates
26.7m KRW

Based on the financial report for Dec 31, 2023, CJ Bioscience Inc's Effect of Foreign Exchange Rates amounts to 26.7m KRW.

What is CJ Bioscience Inc's Effect of Foreign Exchange Rates growth rate?
Effect of Foreign Exchange Rates CAGR 5Y
3%

Over the last year, the Effect of Foreign Exchange Rates growth was -62%. The average annual Effect of Foreign Exchange Rates growth rates for CJ Bioscience Inc have been -13% over the past three years , 3% over the past five years .

Back to Top